Detalles de la búsqueda
1.
Downregulation of miR-17~92 Expression Increase Paclitaxel Sensitivity in Human Ovarian Carcinoma SKOV3-TR30 Cells via BIM Instead of PTEN.
Int J Mol Sci
; 14(2): 3802-16, 2013 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23396109
2.
Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.
Value Health
; 12(6): 872-9, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19490556
3.
First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis.
Hemasphere
; 8(5): e74, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38803455
4.
Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis.
Am Heart J
; 154(6): 1221-7, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18035097
5.
Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents.
Circulation
; 111(3): 321-7, 2005 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-15655127
6.
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.
Diabetes Care
; 39(7): 1241-9, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26681715
7.
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
Circulation
; 110(5): 508-14, 2004 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-15262844
8.
Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.
Diabetes Care
; 40(6): 808, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28420698
9.
Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial.
Can J Cardiol
; 27(2): 222-31, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21459271
10.
Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.
Diabetes Care
; 39(11): e199-e200, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27926898
11.
Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes.
J Am Coll Cardiol
; 52(22): 1758-68, 2008 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19022155
12.
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
J Am Coll Cardiol
; 48(2): 253-61, 2006 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-16843171
13.
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.
J Am Coll Cardiol
; 47(7): 1350-5, 2006 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-16580520
Resultados
1 -
13
de 13
1
Próxima >
>>